Gidazepam and its Lively metabolite desalkygidazepam are benzodiazepines which could shortly come to be drugs of abuse.This will likely result in the incorrect interpretation of a false beneficial immunoassay-based mostly BZD end result. A research in Sweden located that forty% of presumably false-optimistic BZD final results essentially contained

Look and disappearance of various designer benzodiazepines (DBZDs) and etizolam/phenazepam in Sweden throughout 2012-2016 analyzed as Component of the STRIDA task. Disappearance of the DBZD usually coincides With all the time of managed material classification (represented with the arrows).This could produce the incorrect interpretation of a false